Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food effect on levoketoconazole PK in healthy subjects
NCT03768388Phase 1Completed
- Sponsor
- Strongbridge Biopharma
- Start
- Nov 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of levoketoconazole in Cushing's syndrome (2 arms), sponsored by Strongbridge Biopharma. Primary endpoints: Maximum observed plasma concentration at 24 hours, Time to maximum concentration at 24 hours and 3 more. Started Nov 2018; status: completed.
02
Drugs
levoketoconazole
03
Conditions
Cushing's syndrome
Beyond the preview
Go deeper on NCT03768388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03768388.